Clinical Trial Update: A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC) [Phase 2]

View source ↗

Summary

A single-center Phase 2 randomized trial evaluated the duration of action of brimonidine tartrate ophthalmic solution for ocular redness caused by conjunctival …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• brimonidine tartrate ophthalmic solution (brimonidine tartrate)

Snippet

Sponsor: Eye Therapies, LLC | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED